💸 Weekly Funding Recap: November 6

📇 Company: Resilience Care
🏷️ Sectors: HealthTech, MedTech
🔍 Description: Develops digital healthcare platforms that enable medical professionals to remotely monitor patients with chronic diseases. Created in partnership with France's Gustave Roussy cancer institute, Resilience combines clinical monitoring software for healthcare providers with a mobile application for patients. Originally focused on oncology, the company is expanding into psychiatry and gastroenterology.
💻 Website: https://www.resilience.care/
📍 HQ City: Paris
🧗 Round: Growth equity
💰 Amount Raised: €48 million
🏦 Investors: PSG Equity
👨‍💼👩‍💼 Founders: Céline Lazorthes, Jonathan Benhamou
🗞️ News: November 5, 2026. Paris-based digital health company Resilience Care raised €48M from American growth equity firm PSG Equity to expand beyond cancer care into psychiatry and gastroenterology and accelerate international growth through acquisitions. Developed with Gustave Roussy, Resilience's remote monitoring platform has supported more than 40,000 oncology patients across approximately 200 French healthcare institutions. The company has established partnerships with 12 healthcare facilities in Germany, acquired German psychiatric monitoring startup Recovery Cat in September 2026, and recruited a U.S. commercial team. PSG Equity's investment will support expansion into additional disease categories and international markets, including acquisitions of companies with established reimbursement arrangements. Resilience aims to reach group-level profitability by the second quarter of 2027. The financing is described as a growth equity investment; a buyout or transfer of controlling ownership has not been established. | Les Echos